Entries by Barry Baumel

University of Miami Researchers Receive $12.6 Million NIH Grant to Study Genetics of Alzheimer’s Disease

Researchers from the University of Miami Miller School of Medicine’s John P. Hussman Institute for Human Genomics are part of a five-university collaboration receiving a $12.6 million, four-year grant from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to identify rare genetic variants that may either protect against, or […]

Reducing Risk Factors Can Help Maintain Independence

Maintaining an independent daily life is of the key issues for Alzheimer’s disease patients and their families. An individual who can perform the activities of daily living, such as eating, taking a shower, making meals and using the toilet usually does not need round-the-clock assistance. A new study, “Dementia and dependence: Do modifiable risk factors […]

Dietary supplement ‘like a touch of magic’ for Alzheimer’s patients

Miller School study finds dramatic improvements in cognitive functioning When Rina Torres was diagnosed with Alzheimer’s in her 70s, she gradually lost her ability to communicate or recognize family members. Then, she joined a University of Miami Miller School of Medicine study to test if a dietary supplement, aloe polymannose multinutrient complex (APMC), might improve […]

The Interdisciplinary UM Memory Program 

The UM Memory Program is a new and exciting joint collaboration between the University of Miami Miller School of Medicine Department of Neurology and Department of Psychiatry and Behavioral Sciences. The program’s co-directors are Clinton Wright, MD and Elizabeth Crocco, MD. They are joined by Dr. Barry Baumel as the attending physicians at the UM […]

Miller School Study Finds Effective Approach for Delivering Stem Cells to Repair Stroke Damage

A new Miller School research study has identified a safe and effective route for delivering stem cells to the brain, where they can potentially repair stroke-damaged tissue. “Our team found that delivering a low dose of mesenchymal stem cells (MSCs) through the carotid artery at 24 hours after stroke resulted in effective therapy for ischemic […]